Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Equity (2024 - 2026)

Indivior Pharmaceuticals has reported Return on Equity over the past 3 years, most recently at 0.02% for Q1 2026.

  • For Q1 2026, Return on Equity fell 2.0% year-over-year to 0.02%; the TTM value through Mar 2026 reached 0.02%, down 2.0%, while the annual FY2025 figure was 0.01%, 1.0% down from the prior year.
  • Return on Equity for Q1 2026 was 0.02% at Indivior Pharmaceuticals, down from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.01% in Q2 2024 and troughed at 0.02% in Q1 2026.
  • A 3-year average of 0.0% and a median of 0.0% in 2024 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: changed 0bps in 2025 and later fell -2bps in 2026.
  • Year by year, Return on Equity stood at 0.0% in 2024, then tumbled by -6264bps to 0.01% in 2025, then crashed by -51bps to 0.02% in 2026.
  • Business Quant data shows Return on Equity for INDV at 0.02% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.